Abstract
In the past ten years, binding sites for more than two dozen neurotransmitters and hormones have been identified. With the exception of the thyroid and steroid hormone receptors, all neurotransmitter and peptide receptors have thus far been localized to the cell surface of the target organ. It has become clear that the membranes of most cells are endowed with a remarkably heterogeneous population of receptor sites.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarons, R. D., Nies, A. S., Gal, J., Hegstrand, L. R., & Molinoff, P. B. (1980). Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. Journal of Clinical Investigation, 65, 949–957.
Alexander, R. W. (1987). Adrenergic receptors in cardiovascular disease. In P. A. Insel (Ed.), Adrenergic receptors in man. New York: Dekker.
Andersson, R. G. G., Nilsson, O. R., & Kuo, J. F. (1983). Beta-adrenoceptor-adenosine 3′-5′ monophosphate system in human leukocytes before and after treatment for hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 56, 42–45.
Ariëns, E. J. (1954). Affinity and intrinsic activity in the theory of competitive inhibition. Part I. Problems and theory. Archives Internationales de Pharmacodynamie, 99, 32–49.
Banerjee, S. P., Kung, L. S., Riggi, S. J., & Chanda, S. K. (1977). Development of beta adrenergic receptor subsensitivity by antidepressants. Nature, 268, 455–456.
Bannister, R., Boylston, A. W., Davies, I. B., Mathias, C. J., Sever, P. S., & Sudera, D. (1981). Beta-receptor numbers and thermodynamics in denervation supersensitivity. Journal of Physiology (London) 319, 369–377.
Benovic, J. L., Mayor, F., Jr., Somers, R. L., Caron, M. G., & Lefkowitz, R. J. (1986). Light-dependent phosphorylation of rhodopsin by β-adrenergic receptor kinase. Nature, 321, 869–872.
Berthelsen, S., & Pettinger, W. A. (1977). A functional basis for classification of α-adrenergic receptors. Life Sciences, 21, 595–606.
Bilezikian, J. P., & Loeb, J. N. (1983). The influence of hyperthyroidism and hypothyroidism on alpha-and beta-adrenergic receptor systems and adrenergic responsiveness. Endocrine Reviews, 4, 378–388.
Boon, N. A., Elliott, J. M., Davies, C. L., Conway, F. J., Jones, J. V., Grahame-Smith, D. G., & Sleight, P. (1983). Platelet α2-adrenoreceptors in borderline and established essential hypertension. Clinical Science, 65, 207–208.
Bourne, H. R. (1986). One molecular machine can transduce diverse signals. Nature, 321, 814–816.
Bravo, E. L., Tarazi, R. C., Gifford, R. W., & Stewart, B. H. (1979). Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. New England Journal of Medicine, 301, 682.
Brodde, O.-E. (1986). Molecular pharmacology of β-adrenoceptors. Journal of Cardiovascular Pharmacology, 8 (Suppl. 4), S16–S20.
Brodde, O.-E., Daul, A., & O’Hara, N. (1984). Beta-adrenoceptor changes in human lymphocytes induced by dynamic exercise. Naunyn-Schmiedebergs Archives of Pharmacology, 325, 190.
Brodde, O.-E., Daul, A. E., O’Hara, N., & Khalifa, A. M. (1985). Properties of α-and β-adrenoceptors in circulating blood cells of patients with essential hypertension. Journal of Cardiovascular Pharmacology, 7 (Suppl. 6), S162–S167.
Bürgisser, E., Raine, A. E. G., Erne, P., Kamber, B., & Bühler, F. R. (1986). Human cardiac plasma concentrations of atrial natriuretic peptide quantified by radioreceptor assay. Biochemical and Biophysical Research Communications, 133, 1201–1209.
Butler, J., Kelly, J. G., O’Malley, K., & Pidgeon, F. (1983). Beta-adrenergic adaptation to acute exercise. Journal of Physiology (London), 344, 1131.
Cameron, O. G., Smith, C. B., Hollingsworth, P. J., Nesse, R. M., & Curtis, G. C. (1984). Platelet α2 adrenergic receptor binding and plasma catecholamines. Archives of General Psychiatry, 41, 1144–1148.
Chobanian, A. V., Tifft, C. P., Sackel, H., & Pitruzella, A. (1982). Alpha and beta adrenergic receptor activity in circulating blood cells of patients with idiopathic orthostatic hypotension and pheochromocytoma. Clinical and Experimental Hypertension, A4, 793–806.
Cognini, G., Piantanelli, L., Paolinelli, E., Orlandoni, P., Pelligrini, A., & Masera, N. (1983). Decreased beta-adrenergic receptor density in mononuclear leukocytes from thyroidectomized patients. Acta Endocrinologica, 103, 1–5.
Colucci, W. S., Alexander, R. W., Williams, G. H., Rude, R. E., Holman, B. L., Konstam, M. A., Wynne, J., Mudge, G. H., Jr., & Braunwald, E. (1981). Decreased lymphocyte beta-adrenergic receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. New England Journal of Medicine, 305, 185–189.
Cryer, P. E. (1987). Adrenergic receptors in endocrine and metabolic diseases. In P. A. Insel (Ed.), Adrenergic receptors in man (pp. 285–301). New York: Dekker.
Cundell, D., Danks, J., Phillips, M. J., & Davies, R. J. (1984). Effect of exercise on isoprenaline-induced lymphocyte cAMP production in atopic asthmatics and atopic and non-atopic, non-asthmatic subjects. Clinical Allergy, 24, 433.
Daiguji, M., Meltzer, H. Y., Tang, C., & U’Prichard, D. C. (1981). Alpha-2-adrenergic receptors in platelet membranes of depressed patients: No change in number of 3H-yohimbine affinity. Life Sciences, 29, 2059–2064.
Davies, I. B., Sudera, D., Sagnella, G., Marchesi-Saviotti, E., Mathias, C., Bannister, R., & Sever, P. (1982). Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man. Journal of Clinical Investigation, 69, 779–784.
DeBlasi, A., Lipartiti, M., Motulsky, H. J., Insel, P. A., & Fratelli, M. (1985). Agonist-induced redistribution of betaadrenergic receptors on intact human mononuclear leukocytes: Redistributed receptors are nonfunctional. Journal of Clinical Endocrinology and Metabolism, 61, 1081.
DeBlasi, A., Cotecchia, S., Fratelli, M., & Lipartiti, M. (1986). Agonist-induced beta-adrenoceptor internalization of intact human mononuclear leukocytes: Effects of temperature of mononuclear separation. Journal of Laboratory and Clinical Medicine, 107, 86.
DeBlasi, A., Maisel, A. S., Feldman, R. D., Ziegler, M. G., Fratelli, M., Dilallo, M., Smith, D. A., Lai, C. Y. C., & Motulsky, H. J. (1986). In vivo regulation of β-adrenergic receptors on human mononuclear leukocytes: Assessment of receptor number, location, and function after posture change, exercise, and isoproterenol infusion. Journal of Clinical Endocrinology and Metabolism, 63, 847–853.
DeLean, A., Hancock, A. A., & Lefkowitz, R. J. (1982). Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand-binding data for mixtures of pharmacological receptor subtypes. Molecular Pharmacology, 21, 5–16.
DeLean, A., Racz, K., Gutkowska, J., Nguyen, T.-T., Cantin, M., & Genest, J. (1984). Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormonestimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology, 115, 1636–1638.
Docherty, J. R., & O’Malley, K. (1985). Aging and alphaadrenoceptors. Clinical Science, 68 (Suppl. 10), 133S–136S.
Edwards, A. J., Bacon, T. H., Elms, C. A., Verardi, R., Felder, M., & Knight, S. C. (1984). Changes in the populations of lymphoid cells in human peripheral blood following physical exercise. Clinical and Experimental immunology, 58, 420.
Engel, G., Hoyer, D., Berthold, R., & Wagner, H. (1981). (±)-125Iodocyanopindolol, a new ligand for β-adrenoceptors: Identification and quantitation of subclasses of β-adrenoceptors in guinea-pig. Naunyn-Schmiedeberg’s Archives of Pharmacology, 317, 277–285.
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986). Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science, 231, 258–261.
Feldman, R. D., Limbird, L. E., Nadeau, J. H., FitzGerald, G. A., Robertson, D., & Wood, A. J. J. (1983). Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines. Journal of Clinical Investigation, 72, 164.
Feldman, R. D., Limbird, L. E., Nadeau, J. H. J., Robertson, D., & Wood, A. J. J. (1984a). Alterations in leukocyte β-receptor affinity with aging: A potential explanation for altered β-adrenergic sensitivity in the elderly. New England Journal of Medicine, 310, 815–819.
Feldman, R. D., Limbird, L. E., Nadeau, J. H., Robertson, D., & Wood, A. J. J. (1984b). Leukocyte beta-receptor alterations in hypertensive subjects. Journal of Clinical Investigation, 73, 648.
Fraser, J. A., Nadeau, J. H. J., Robertson, D., & Wood, A. J. J. (1981). Regulation of human leukocyte beta receptors by endogenous catecholamines: Relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. Journal of Clinical Investigation, 67, 1777–1784.
Gaddum, J. H. (1957). Theories of drug antagonism. Pharmacological Reviews, 9, 211–217.
Garcia-Sevilla, J. A., Zia, A. P., Hollingsworth, P. J., Greden, J. F., & Smith, C. B. (1981). Platelet alpha2-adrenergic receptors in major depressive disorder: Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment. Archives of General Psychiatry, 38, 1327–1333.
Garnett, E. S., Firnau, G., & Nahmias, C. (1983). Dopamine visualized in the basal ganglia of living man. Nature, 305, 137–138.
Ginsberg, A. M., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1981). Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man. Journal of Clinical Investigation, 67, 1785–1791.
Goldberg, M. R., & Robertson, D. (1983). Yohimbine: A pharmacological probe for study of the α2-adrenergic receptor. Pharmacological Reviews, 35, 143–180.
Goldberg, M. R., & Robertson, D. (1984). Evidence for the existence of vascular α2-adrenoreceptors in man. Hypertension, 6, 551–556.
Goldberg, M. R., Curatolo, P. W., Tung, C. S., & Robertson, D. (1982). Caffeine down-regulates β-adrenoreceptor density in rat forebrain. Neuroscience Letters, 31, 47–52.
Goldberg, M. R., Hollister, A. S., & Robertson, D. (1983). Influence of yohimbine on blood pressure, autonomic reflexes and plasma catecholamines. Hypertension, 5, 772–778.
Goldstein, A., Aronow, L., & Kaiman, S. M. (1974). Principles of drug action: The basis of pharmacology (2nd ed., pp. 82–111). New York: Wiley.
Greenacre, J. K., & Conolly, M. E. (1978). Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and patients with phaeochromocytoma: Studies in vivo. British Journal of Pharmacology, 5, 191–197.
Grenningloh, G., Rienitz, A., Schmitt, B., Methfessel, C., Zensen, M., Beyreuther, K., Gundelfinger, E. D., & Betz, H. (1987). The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors. Nature, 328, 215–220.
Guarnieri, T., Filburn, C. R., Zitnik, G. S., & Lakatta, E. G. (1980). Contractile and biochemical correlates of beta-adrenergic stimulation of the aged heart. American Journal of Physiology, 239, H501–H508.
Hantraye, P., Loc’h, C., Tacke, U., Riche, D., Stulzaft, O., Doudet, D., Guibert, B., Naquet, R., Maziere, B., & Maziere, M. (1986). “In vivo” visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates. Life Sciences, 39, 1376–1378.
Harden, T. K. (1983). Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacological Reviews, 35, 5.
Hoeldtke, R. D., & Climi, K. M. (1985). Effects of aging on catecholamine metabolism. Journal of Clinical Endocrinology and Metabolism, 60, 479–484.
Hoffman, J. W., Benson, H., Arns, P. A., Stainbrook, G. L., Landsberg L., Young, J. B., & Gill, A. (1982). Reduced sympathetic nervous system responsivity associated with the relaxation response. Science, 215, 190–192.
Hollister, A. S., FitzGerald, G. A., Nadeau, J. H. J., & Robertson, D. (1983). Acute reduction in human platelet α2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines. Journal of Clinical Investigation, 72, 1498–1505.
Hollister, A. S., Onrot, J., Lonce, S., Nadeau, J. H. J., & Robertson, D. (1986). Plasma catecholamine modulation of α2-adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets. Journal of Clinical Investigation, 77, 1416–1421.
Hollister, A. S., Tanaka, I., Imada, T., Onrot, J., Biaggioni, I., Kincaid, D., Robertson, D., & Inagami, T. (1986). Sodium loading and posture modulate human atrial natriuretic factor plasma levels. Hypertension, 8, II106–11111.
Hui, K. K. P., & Conolly, M. E. (1981). Increased numbers of beta receptors in orthostatic hypotension due to autonomic dysfunction. New England Journal of Medicine, 304, 1473–1476.
Hui, K. K. P., Wolfe, R. N., & Conolly, M. E. (1982). Lymphocyte beta-adrenergic receptors are not altered in hyperthyroidism. Clinical Pharmacology and Therapeutics, 32, 161–165.
Insel, P. A., & Motulsky, H. J. (1987). Adrenergic receptors in man. New York: Raven Press.
Jennings, G., Bobik, A., & Esler, M. (1981). Beta receptors in orthostatic hypotension. New England Journal of Medicine, 305, 1019.
Kafka, M. S., Polinsky, R. J., Williams, A., Kopin, I. J., Lake, C. R., Ebert, M. H., & Tokola, N. A. (1984). Alphaadrenergic receptors in orthostatic hypotension syndromes. Neurology, 34, 1121–1125.
Karliner, J. S., Motulsky, H. J., & Insel, P. A. (1982). Apparent “down-regulation” of human platelet alpha2-adrenergic receptors is due to retained agonist. Molecular Pharmacology, 21, 36–43.
Kenakin, T. P. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacological Reviews, 36, 165–222.
Krall, J. F., Connelly, M., & Tuck, M. L. (1980). Acute regulation of beta adrenergic catecholamine sensitivity in human lymphocytes. Journal of Pharmacology and Experimental Therapeutics, 214, 554.
Kubo, T., Fukuda, K., Mikami, A., Maeda, A., Takahashi, H., Mishina, M., Haga, T., Haga, K., Ichiyama, A., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., & Numa, S. (1986). Cloning, sequencing, and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature, 323, 411–416.
Kuhar, M., & Unnerstall, J. R. (1985, February). Quantitative receptor mapping by autoradiography: Some current technical problems. Trends in Neurological Science, 49-53.
Lefkowitz, R. J., & Caron, M. G. (1986). Regulation of adrenergic receptor function by phosphorylation. Journal of Molecular and Cellular Cardiology, 18, 885–895.
Levitzki, A. (1984). Receptors: A quantitative approach. Menlo Park: Benjamin/Cummings.
Limbird, L. E. (1986). Cell surface receptors: A short course on theory and methods. The Hague: Nijhoff.
Mahan, L. C., Motulsky, H. J., & Insel, P. A. (1985). Do agonists promote rapid internalization of β-adrenergic receptors?. Proceedings of the National Academy of Sciences of the United States of America, 82, 6566–6570.
Mahan, L. C., McKernan, R. M., & Insel, P. A. (1987). Metabolism of alpha-and beta-adrenergic receptors in vitro and in vivo. Annual Reviews of Pharmacology and Toxicology, 27, 215–235.
Malbon, C. C., Graziano, M. P., & Johnson, G. L. (1984). Fat cell beta-adrenergic receptor in the hypothyroid rat: Impaired interaction with the stimulatory regulatory component of adenylate cyclase. Journal of Biological Chemistry, 259, 3254–3260
Mann, J. J., Brown, R. P., Halper, J. P., Sweeney, J. A., Kocsis, J. H., Stokes, P. E., & Bilezikian, J. P. (1985). Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. New England Journal of Medicine, 313, 715–720.
Metz, A., Cowen, P. J., Gelder, M. G., Stump, K., Elliott, J. M., & Grahame-Smith, D. G. (1983). Changes in platelet alpha2-adrenoceptor binding post-partum: Possible relation to maternity blues. Lancet, 1, 495.
Mohring, J., Glanzer, K., Marciel, J. A., Jr., Dusing, R., Kramer, H. J., Arogast, R., & Koch-Weser, J. (1980). Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. Journal of Cardiovascular Pharmacology, 2, 367–376.
Molinoff, P. B., Wolfe, B. B., & Weiland, G. A. (1981). Quantitative analysis of drug-receptor interactions. II. Determination of the properties of receptor subtypes. Life Sciences, 29, 427–443.
Motulsky, H. J., & Insel, P. A. (1982). Adrenergic receptors in man: Direct identification, physiologic regulation, and clinical alterations. New England Journal of Medicine, 307, 18–28.
Motulsky, H. J., & Mahan, L. C. (1984). The kinetics of competitive radioligand binding predicted by the law of mass action. Molecular Pharmacology, 25, 1–9.
Motulsky, H. J., O’Connor, D. J., & Insel, P. A. (1983). Platelet α2adrenergic receptors in treated and untreated essential hypertension. Clinical Science, 64, 265–272.
Motulsky, H. J., Cunningham, E. M. S., DeBlasi, A., & Insel, P. A. (1986). Agonists promote rapid desensitization and redistribution of beta adrenergic receptors on intact human mononuclear leukocytes. American Journal of Physiology, 250, E583.
Munson, P. J., & Rodbard, D. (1980). LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Analytical Biochemistry, 107, 220.
Nadi, N. S., Nurnberger, J. I., & Gershon, E. S. (1984). Muscarinic cholinergic receptors on skin fibroblasts in familial affective disorder. New England Journal of Medicine, 311, 225–230.
Nickerson, M. (1956). Receptor occupancy and tissue response. Nature, 78, 697–698.
Onrot, J., Goldberg, M. R., Biaggioni, I., Wiley, R., Hollister, A. S., & Robertson, D. (1987). Oral yohimbine in human autonomic failure. Neurology, 37, 215–220.
Pan, H. Y.-M., Hoffman, B. B., Pershe, R. A., & Blaschke, T. F. (1986). Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. Journal of Pharmacology and Experimental Therapeutics, 239, 802–807.
Pandey, G. N., Heinze, W. J., Brown, B. D., & Davis, J. M. (1979). Electroconvulsive shock treatment decreases beta-adrenergic receptor sensitivity in rat brain. Nature, 280, 234–235.
Pfeifer, M. A., Ward, K., Malpass, T., Stratton, J., Halter, J., Evans, M., Beiter, H., Harker, L. A., & Porte, D., Jr. (1984). Variations in circulating catecholamines fail to alter human platelet alpha2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine. Journal of Clinical Investigation, 74, 1063–1072.
Ratge, D., Hansel-Bessey, S., & Wisser, H. (1985). Altered plasma catecholamines and numbers ofα-and β-adrenergic receptors in platelets and leucocytes in hyperthroid patients normalized under antithyroid treatment. Acta Endocrinologica, 110, 75–82.
Reinhardt, D., Zehmisch, T., Becker, B., & Nagel-Hiemke, M. (1984). Age-dependency of alpha-and beta-adrenoceptors on thrombocytes and lymphocytes of asthmatic and nonasthmatic children. European Journal of Pediatrics, 142, 111–116.
Robertson, D., Goldberg, M. R., Hollister, A. S., Wade, D., & Robertson, R. M. (1983). Clonidine raises blood pressure in idiopathic orthostatic hypotension. American Journal of Medicine, 74, 193–199.
Robertson, D., Hollister, A. S., Carey, E. L., Tung, C. S., Goldberg, M. R., & Robertson, R. M. (1984). Increased vascular β2-adrenergic hypersensitivity in autonomic dysfunction. Journal of the American College of Cardiology, 3, 850–856.
Robertson, D., Goldberg, M. R., Hollister, A. S., Tung, C. S., & Robertson, R. M. (1986). Use of α2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. Journal of Clinical Investigation, 78, 576–581.
Robertson, D., Goldberg, M. R., Onrot, J., Hollister, A. S., Wiley, R., Thompson, J. G., & Robertson, R. M. (1986). Isolated failure of autonomic noradrenergic neurotransmission: Evidence for impaired β-hydroxylation of dopamine. New England Journal of Medicine, 314, 1494–1497.
Shattil, S. J., McDonough, M., Turnbull, J., & Insel, P. A. (1981). Characterization of alpha-adrenergic receptors in human platelets using [3H]clonidine. Molecular Pharmacology, 19, 179–183.
Snavely, M. D., Motulsky, H. J., O’Connor, D. T., Ziegler, M. G., & Insel, P. A. (1982). Adrenergic receptors in human and experimental pheochromocytoma. Clinical and Experimental Hypertension, 4, 829–848.
Snyder, S. H. (1984). Cholinergic mechanisms in affective disorders. New England Journal of Medicine, 311, 254–255.
Soppi, E., Varjo, P., Eskola, J., & Laitinen, L. A. (1982). Effect of strenuous physical stress on circulating lymphocyte number and function before and after training. Clinical and Laboratory Immunology, 8, 43.
Sowers, J. R., Connelly-Fittinghoff, M., Tuck, M. L., & Krall, J. F. (1983). Acute changes in noradrenaline levels do not alter lymphocyte beta-adrenergic receptor concentrations in man. Cardiovascular Research, 17, 184.
Stephenson, R. P. (1956). A modification of receptor theory. British Journal of Pharmacology, 11, 379–393.
Stiles, G. L., Caron, M. G., & Lefkowitz, R. J. (1984). Betaadrenergic receptors: Biochemical mechanisms of physiological regulation. Physiological Reviews, 64, 661–743.
Tohmen, J. F., Cryer, P. E. (1980). Biphasic adrenergic modulation of beta-adrenergic receptors in man: Agonist-induced early increment and late decrement in beta-adrenergic receptor number. Journal of Clinical Investigation, 65, 836.
Van Rossum, J. M., & Ariëns, E. J. (1962). Receptor reserve and threshold phenomena. II. Theories on drug-action and a quantitative approach to spare receptors and threshold values. Archives Internationales de Pharmacodynamie, 136, 385–413.
Vetulani, J., & Sulser, F. (1975). Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP generating system in the limbic forebrain of the rat. Nature, 257, 495–496.
Villeneuve, A., Carpene, C., Berlan, M. D., & Lafontan, M. (1985). Lack of desensitization of alpha2-mediated inhibition of lipolysis in fat cells after acute and chronic treatment with clonidine. Journal of Pharmacology and Experimental Therapeutics, 233, 433–440.
Wagner, H. N., Burns, H. D., Dannals, R. F., Wong, D. F., Langstrom, B., Duelfer, T., Frost, J. J., Ravert, H. T., Links, J. M., Rosenbloom, J. B., Luckas, S. E., Kramer, A. V., & Kuhar, M. J. (1983). Imaging dopamine receptors in the human brain by positron tomography. Science, 221, 1264–1266.
Weiland, G. A., & Molinoff, P. B. (1981). Quantitative analysis of drug-receptor interactions. I. Determination of kinetic and equilibrium properties. Life Sciences, 29, 313–330.
Wolfe, N., Cohen, B. M., & Gelenberg, A. J. (1987). Alpha-2-adrenergic receptors in platelet membranes of depressed patients: Increased affinity for 3H-yohimbine. Psychiatric Research, 20, 107–116.
Wong, D. F., Wagner, H. N., Jr., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E. P., Ravert, H. T., Wilson, A. A., Toung, J. K. T., Malat, J., Williams, J. A., O’Tuama, L. A., Snyder, S. H., Kuhar, M. J., & Gjedde, A. (1986). Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science, 234, 1558–1562.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Robertson, D., Parfyonova, Y., Menshikov, M., Hollister, A.S. (1989). Receptors. In: Schneiderman, N., Weiss, S.M., Kaufmann, P.G. (eds) Handbook of Research Methods in Cardiovascular Behavioral Medicine. The Springer Series in Behavioral Psychophysiology and Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0906-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0906-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0908-4
Online ISBN: 978-1-4899-0906-0
eBook Packages: Springer Book Archive